TREM2 and Alzheimer disease: Here, we used human iPSC‐derived microglia (iPS‐Mg) generated from donors harboring specific TREM2 mutations previously characterized as hypomorphic variants in Alzheimer’s disease and Nasu Hakola disease (NHD), and identified deficits in microglial metabolic regulation and associated functions.